Iron-chelation therapy with oral chelators in patients with thalassemia major

By Uygun Vedat  

Hematology, Vol. 18, Iss. 1, 2013-01 ,pp. : 50-55

Maney Publishing

Access to resources Recommend Favorite

Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with -thalassemia major

By Wu K.  

Annals of Hematology, Vol. 83, Iss. 7, 2004-07 ,pp. : 471-473

Springer Publishing Company

Access to resources Recommend Favorite

The Egyptian experience with oral iron chelators

By Beshlawy Prof. Amal El  

Hematology, Vol. 10, Iss. 1, 2005-09 ,pp. : 174-175

Maney Publishing

Access to resources Recommend Favorite

Iron chelation in thalassemia: combined or monotherapy? The Egyptian experience

By El-Beshlawy Amal   Manz Chantal   Naja Mohammed   Eltagui Mona   Tarabishi Claudia   Youssry Ilham   Sobh Hewida   Hamdy Mona   Sharaf Iman   Mostafa Azza   Shaker Olfat   Hoffbrand A.   Taher Ali  

Annals of Hematology, Vol. 87, Iss. 7, 2008-07 ,pp. : 545-550

Springer Publishing Company

Access to resources Recommend Favorite

Oral Isobutyramide Therapy in Patients with Thalassemia Intermedia: Results of a Phase II Open Study

By Domenica Cappellini M.   Graziadei G.   Ciceri L.   Comino A.   Bianchi P.   Porcella A.   Fiorelli G.  

Blood Cells, Molecules, and Diseases, Vol. 26, Iss. 1, 2000-02 ,pp. : 105-111

Academic Press

Access to resources Recommend Favorite